Table 1.
Demographic and clinical characteristics of the postmenopausal women with hormone‐receptor positive breast cancer who were included in the study
| Mean ± SD | n | Range | % | |
|---|---|---|---|---|
| Age at therapy onset (years) | 56.74 ± 27.88 | 39–80 | ||
| Body mass index (kg m –2 ) | 28.69 ± 4.52 | 18.72–40.43 | ||
| Age at menopause (years) | 49.35 ± 4.96 | 30–58 | ||
| Chemotherapy | ||||
| Yes | 100 | 90.9 | ||
| No | 10 | 9.1 | ||
| Grade | ||||
| 1 | 24 | 21.8 | ||
| 2 | 54 | 49.1 | ||
| 3 | 32 | 29.1 | ||
| Stage | ||||
| IA | 41 | 37.3 | ||
| IIA | 32 | 29.1 | ||
| IIB | 17 | 15.5 | ||
| IIIA | 10 | 9.1 | ||
| IIIB | 7 | 6.4 | ||
| IIIC | 3 | 2.7 | ||
| HER2 | ||||
| Negative | 90 | 81.8 | ||
| Positive | 20 | 18.2 | ||
| Ki67 expression | ||||
| < 10 | 34 | 30.9 | ||
| 10–20 | 44 | 40.0 | ||
| > 20 | 32 | 29.1 | ||